Achievements, Challenges, and Future Directions of Patient Engagement in the PMDA
Iryo To Shakai · 14.07.2026 · 36 (1) · 55-65
DOI: 10.4091/iken.36-55 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iryo To Shakai, erschienen am 14.07.2026. Verfasst von Shun Tezuka und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
The Pharmaceuticals and Medical Devices Agency(PMDA)formally initiated patient engagement activities in 2019, establishing a cross-divisional Patient Engagement Working Group and subsequently publishing the PMDA Patient Engagement Guidance in 2021. While European and U.S. regulatory authorities began engaging patient representatives in the late 1980s and 1990s, PMDA has since made steady progress through opinion exchanges with patients, collaborative development of patient-facing materials with patient organizations, promotion of understanding of the pharmaceutical regulatory system, and exploration of patient-reported outcomes(PROs)in regulatory decision-making. A critical self-assessment revealed challenges including insufficient continuity and bidirectionality of activities, limited opportunities for incorporating patient voices into the review process, and narrow participation. To address these challenges, PMDA launched disease-specific opinion exchange meetings in 2025 as a new initiative, informed by the recognized need to broaden patient participation, strengthen proactive outreach, create opportunities for frank and bidirectional dialogue, develop patient education programs, and establish a comprehensive framework for utilizing patient voices. Furthermore, at the International Council for Harmonisation(ICH), development of guideline E22 on Patient Preference Studies is underway, with potential to advance patient engagement through scientific evidence including PROs and patient preferences. This article reviews PMDA’s patient engagement achievements, challenges, and future directions.
Zitieren
APA
Tezuka, S., & Fujiwara, Y. (2026). Achievements, Challenges, and Future Directions of Patient Engagement in the PMDA. Iryo To Shakai, 36(1), 55-65. https://doi.org/10.4091/iken.36-55
Vancouver
Tezuka S, Fujiwara Y. Achievements, Challenges, and Future Directions of Patient Engagement in the PMDA. Iryo To Shakai. 2026;36(1):55-65. doi:10.4091/iken.36-55
BibTeX
@article{Tezuka2026,
author = {Tezuka, Shun and Fujiwara, Yasuhiro},
title = {Achievements, Challenges, and Future Directions of Patient Engagement in the PMDA},
journal = {Iryo To Shakai},
year = {2026},
volume = {36},
number = {1},
pages = {55--65},
doi = {10.4091/iken.36-55}
}
EUVIMED